As part of a deferred prosecution agreement, Johnson & Johnson has agreed to pay a $21.4 million criminal penalty to resolve improper payments by J&J subsidies to European government officials and the former government of Iraq, according to a news release from the U.S. Department of Justice.
The agreement resolves kickbacks that New Brunswick, N.J.-based J&J and its subsidiaries paid former government of Iraq under the United Nations Oil for Food Program to secure contracts to provide humanitarian supplies. J&J also admitted its subsidiaries, including DePuy, paid bribes to publicly-employed providers in Greece, Poland and Romania to induce the purchase of medical devices and pharmaceuticals — a violation of the Foreign Corrupt Practices Act.
In a related matter, J&J reached a settlement with the Securities and Exchange Commission under which it agreed to pay more than $48.6 million in disgorgement of profits, including pre-judgment interest.
Read the release on Johnson & Johnson.
Read more about Johnson & Johnson:
- Former Johnson & Johnson Employee Files Whistleblower Suit Alleging Medicaid Fraud
- Mass General Develops Cancer Test; Johnson & Johnson Partnership Expected
The agreement resolves kickbacks that New Brunswick, N.J.-based J&J and its subsidiaries paid former government of Iraq under the United Nations Oil for Food Program to secure contracts to provide humanitarian supplies. J&J also admitted its subsidiaries, including DePuy, paid bribes to publicly-employed providers in Greece, Poland and Romania to induce the purchase of medical devices and pharmaceuticals — a violation of the Foreign Corrupt Practices Act.
In a related matter, J&J reached a settlement with the Securities and Exchange Commission under which it agreed to pay more than $48.6 million in disgorgement of profits, including pre-judgment interest.
Read the release on Johnson & Johnson.
Read more about Johnson & Johnson:
- Former Johnson & Johnson Employee Files Whistleblower Suit Alleging Medicaid Fraud
- Mass General Develops Cancer Test; Johnson & Johnson Partnership Expected